Form 8-K - Current report:
SEC Accession No. 0001558370-17-005262
Filing Date
2017-07-24
Accepted
2017-07-21 20:25:55
Documents
4
Period of Report
2017-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 52101
2 EX-5.1 ex-5d1.htm EX-5.1 18606
3 EX-10.1 ex-10d1.htm EX-10.1 229235
4 GRAPHIC ex-5d1g001.jpg GRAPHIC 10840
  Complete submission text file 0001558370-17-005262.txt   316200
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 17977422
SIC: 2834 Pharmaceutical Preparations